Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

da Vinci Single Port: U-RATS lobectomy

Study summary

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.

Eligibility

Primary outcome measure(s)

• Evaluation of experience — "From enrollment to the end of 5 year follow-up
  The objective of this study is to collect and describe IEO experiences in the use of the Da Vinci SP surgical system for anatomical lung resection.

Trial sites (1)

More European Institute of Oncology trials in Italy

Other trials for the same condition